The relationship between total anticholinergic burden (ACB) and early in-patient hospital mortality and length of stay in the oldest old aged 90 years and over admitted with an acute illness

Archives of Gerontology and Geriatrics

Volumn 59, Issue 1, 2014, Pages 155-161

  Kidd, Andrew C ^a,b   Musonda, Patrick ^a   Soiza, Roy L ^c,d   Butchart, Catherine ^c   Lunt, Claire J ^c   Pai, Yogish ^e   Hameed, Yasir ^f   Fox, Chris ^a   Potter, John F ^a,b   Myint, Phyo Kyaw ^c,d  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c WOODEND HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^f NORFOLK AND SUFFOLK NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

ACB; Length of stay; Mortality; Oldest old

Indexed keywords

AMITRIPTYLINE; ATENOLOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CODEINE; CREATININE; DIGOXIN; FUROSEMIDE; ISOSORBIDE MONONITRATE; MORPHINE; PREDNISOLONE; RANITIDINE; UREA;

ACUTE DISEASE; AGED; AGED HOSPITAL PATIENT; ANTICHOLINERGIC BURDEN; ANTICHOLINERGIC COGNITIVE BURDEN SCALE; ANTICHOLINERGIC EFFECT; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMENTIA; DRUG USE; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME; UREA BLOOD LEVEL; VERY ELDERLY;

ACB; LENGTH OF STAY; MORTALITY; OLDEST OLD;

ACUTE DISEASE; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; ENGLAND; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SCOTLAND;

EID: 84900872756     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2014.01.006     Document Type: Article

References (22)

1. Ancelin M.L., Artero S., Portet F., Dupuy A.-M., Touchon J., Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study. British Medical Journal 2006, 332(7539):455-459.
2. Blazer D.G., Federspiel C.F., Ray W.A., Schaffner W. The risk of anticholinergic toxicity in the elderly: A study of prescribing practices in two populations. Journal of Gerontology 1983, 38:31-35.
3. Boustani M.A., Campbell N.L., Munger S., et al. Impact of anticholinergics on the aging brain: A review and practical application. Aging Health 2008, 4:311-320.
4. Cai X., Campbell N., Khan B., Callahan C., Boustani M. Long-term anticholinergic use and the aging brain. Alzheimers Dement 2013, 9(4):377-385.
5. Campbell N.L., Boustani M.A., Lane K.A., et al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology 2010, 75:152-159.
6. Campbell N., Boustani M., Limbil T., Ott C., Fox C., Maidment I., et al. The cognitive impact of anticholinergics: A clinical review. Clin Interv Aging 2009, 4:225-233.
7. Carriere I., Fourrier-Reglat A., Dartigues J.F., Rouaud O., Pasquier F., Ritchie K. Drugs with anticholinergic properties, cognitive decline, dementia in an elderly general population-the 3-city study. Archives of Internal Medicine 2009, 169:1317-1324.
8. Chew M.L., Mulsant B.H., Pollock B.G. Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. American Journal of Geriatric Psychiatry 2005, 13(6):535-538.
9. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs and Aging 1993, 3:335-348.
10. Fox C., Richardson K., Maidment I., Savva G., Matthews F., Smithard D., et al. Anticholinergic medication use and cognitive impairment in the older population: The medical research council cognitive function and ageing study. Journal of the American Geriatrics Society 2011, 59(8):1477-1483.
11. Gnjidic D., Hilmer S.N., Blyth F.M., Naganathan V., Cumming R.G., Handelsman D.J., et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clinical Pharmacology and Therapeutics 2012, 91(3):521-528.
12. Han L., Agostini J.V., Allore H.G. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. Journal of the American Geriatrics Society 2008, 56(12):2203-2210.
13. Kumpula E., Bell J.S., Soini H., Pitkälä K.H. Anticholinergic drug use and mortality among residents of long-term care facilities: A prospective cohort study. Journal of Clinical Pharmacology 2011, 51(2):256-263.
14. Lönnroos E., Gnjidic D., Hilmer S.N., Bell J.S., Kautiainen H., Sulkava R., et al. Drug burden index and hospitalization among community-dwelling older people. Drugs and Aging 2012, 29(5):395-404.
15. Lowry E., Woodman R.J., Soiza R.L., Mangoni A.A. Clinical and demographic factors associated with antimuscarinic medication use in older hospitalized patients. Hospital Practice 2011, 39(1):30-36.
16. Mangoni A., van Munster B., Woodman R., de Rooij S. Measures of Anticholinergic Drug Exposure. Serum Anticholinergic Activity, and All-cause Postdischarge Mortality in Older Hospitalized Patients with Hip Fractures. The American Journal of Geriatric Psychiatry 2013, 21(8):785-793.
17. Pai Y., Butchart C., Lunt C.J., Musonda P., Gautham N., Soiza R.L., et al. Age, co-morbidity and poor mobility: No evidence of predicting in-patient death and acute hospital length of stay in the oldest old. QJM 2011, 104:671-679.
18. Pasina L., Djade C.D., Lucca U., Nobili A., Tettamanti M., Franchi C., et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: Comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: Results from the REPOSI study. Drugs and Aging 2013, 30(2):103-112.
19. Tune L.E. Anticholinergic effects of medications in elderly patients. Journal of Clinical Psychiatry 2001, 62(21):11-14.
20. Uusvaara J., Pitkala K.H., Kautiainen H., Tilvis R.S., Strandberg T.E. Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: A prospective study. Drugs and Aging 2011, 28(2):131-138.
21. Wilson N., Hilmer S., March L., Chen J., Gnjidic D., Mason R., et al. Associations between drug burden index and mortality in older people in residential aged care facilities. Drugs and Aging 2012, 29(2):157-165.
22. Zhao J., Barclay S., Farquhar M., Kinmonth A.L., Brayne C., Fleming J. The oldest old in the last year of life: Population-based findings from Cambridge city over-75s cohort study participants aged 85 and older at death. Journal of the American Geriatrics Society 2010, 58:1-11.